Skip to main content
# Title Department Research Year
171 Design and optimization of PEGylated silver nanoparticles for efficient delivery of Doxorubicin to cancer cells Department of Industrial Pharmacy 2022
172 New Cell Cycle Checkpoint Pathways Regulators with 2-Oxo-indoline Scaffold as Potential Anticancer Agents: Design, Synthesis, Biological Activities and In Silico Studies Department of Medicinal Chemistry 2022
173 Design, synthesis, crystal structures and biological evaluation of some 1, 3-thiazolidin-4-ones as dual CDK2/EGFR potent inhibitors with potential apoptotic antiproliferative effects 2022
174 New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization Department of Pharmaceutical Organic Chemistry 2022
175 Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells Department of Pharmaceutics 2022
176 Structure-based design, synthesis and antiproliferative action of new quinazoline-4-one/chalcone hybrids as EGFR inhibitors Department of Pharmaceutical Organic Chemistry 2022
177 Selective Cytotoxic Constituents from Gardenia latifolia and Their In Silico Topoisomerase IIα Inhibition Department of Pharmacognosy 2022
178 Biomedical applications of quantum dots: overview, challenges and clinical potentials Department of Industrial Pharmacy 2022
179 A Comprehensive Review on Analytical Techniques for Determination of Sex Stimulants, PDE5 Inhibitors in Different Matrices with Special Focus on the Electroanalytical Methods Department of Pharmaceutical Analytical Chemistry 2022
180 Antibacterial and wound-healing potential of PLGA/spidroin nanoparticles: a study on earthworms as a human skin model 2022